Metastatic Breast Cancer
Conditions
Keywords
Metastatic Breast Cancer,, retrospective study,, disease progression,, clinical management
Brief summary
The purpose of this study is to evaluate the incidence rate of progression of disease, to describe the diagnostic and clinical management in patients with Metastatic Breast Cancer in the clinical practice in Bulgaria.
Detailed description
A Retrospective Cohort Study on Therapeutic Management of Metastatic Breast Cancer in Clinical Practice in Bulgaria
Interventions
None listed
Sponsors
AstraZeneca
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* New diagnosis of breast cancer according to ICD-10 with confirmed metastasis * Confirmed diagnosis between 1st July 2010 and 30th June 2011. * Female patient managed for her disease at the same setting where final diagnosis of MBC was performed.
Exclusion criteria
* History of concurrent or other primary malignancies (except curatively resected non-melanoma skin cancer or in situ cervical cancer).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of progression events on a per patient-year-basis | Up to 2 years 5 months |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of patients among study population who have not progressed at 12 and 18 months after they were diagnosed | Up to 2 years 5 months |
| Median and mean time interval that elapsed between diagnosis and first objective tumor progression (TTP) event and subsequent events | Up to 2 years 5 months |
| Median and mean time from the date of diagnosis to the date of breast cancer progression or death whichever occurred first | Up to 2 years 5 months |
Countries
Bulgaria
Outcome results
None listed